254 related articles for article (PubMed ID: 18566803)
1. Nicotine and amphetamine acutely cross-potentiate their behavioral and neurochemical responses in female Holtzman rats.
Jutkiewicz EM; Nicolazzo DM; Kim MN; Gnegy ME
Psychopharmacology (Berl); 2008 Sep; 200(1):93-103. PubMed ID: 18566803
[TBL] [Abstract][Full Text] [Related]
2. The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors.
Kim MN; Jutkiewicz EM; Zhang M; Gnegy ME
Neuropharmacology; 2011 Jun; 60(7-8):1126-34. PubMed ID: 20971124
[TBL] [Abstract][Full Text] [Related]
3. Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants.
Dopheide MM; Morgan RE; Rodvelt KR; Schachtman TR; Miller DK
Eur J Pharmacol; 2007 Jul; 568(1-3):112-23. PubMed ID: 17477916
[TBL] [Abstract][Full Text] [Related]
4. Suppressing effect of the novel positive allosteric modulator of the GABA
Lobina C; Maccioni P; Lorrai I; Zaru A; Collu M; Carai MAM; Brizzi A; Mugnaini C; Gessa GL; Corelli F; Colombo G
Behav Brain Res; 2021 Feb; 400():113045. PubMed ID: 33309750
[TBL] [Abstract][Full Text] [Related]
5. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation.
Schoffelmeer AN; De Vries TJ; Wardeh G; van de Ven HW; Vanderschuren LJ
J Neurosci; 2002 Apr; 22(8):3269-76. PubMed ID: 11943828
[TBL] [Abstract][Full Text] [Related]
6. Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.
Carpenter C; Zestos AG; Altshuler R; Sorenson RJ; Guptaroy B; Showalter HD; Kennedy RT; Jutkiewicz E; Gnegy ME
Neuropsychopharmacology; 2017 Sep; 42(10):1940-1949. PubMed ID: 28492278
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute D-amphetamine.
Polissidis A; Chouliara O; Galanopoulos A; Naxakis G; Papahatjis D; Papadopoulou-Daifoti Z; Antoniou K
Behav Brain Res; 2014 Aug; 270():261-9. PubMed ID: 24867330
[TBL] [Abstract][Full Text] [Related]
8. Nicotine Modifies Corticostriatal Plasticity and Amphetamine Rewarding Behaviors in Mice(1,2,3).
Storey GP; Gonzalez-Fernandez G; Bamford IJ; Hur M; McKinley JW; Heimbigner L; Minasyan A; Walwyn WM; Bamford NS
eNeuro; 2016; 3(1):. PubMed ID: 26866057
[TBL] [Abstract][Full Text] [Related]
9. The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum.
Bosse KE; Jutkiewicz EM; Gnegy ME; Traynor JR
Neuropharmacology; 2008 Oct; 55(5):755-62. PubMed ID: 18602932
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine- and nicotine-induced cross-sensitization in adolescent rats persists until adulthood.
Santos GC; Marin MT; Cruz FC; Delucia R; Planeta CS
Addict Biol; 2009 Jul; 14(3):270-5. PubMed ID: 19523043
[TBL] [Abstract][Full Text] [Related]
11. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
J Pharmacol Exp Ther; 2008 Feb; 324(2):714-24. PubMed ID: 17986650
[TBL] [Abstract][Full Text] [Related]
12. The effects of nicotine on dopamine and DOPAC output from rat striatal tissue.
Dluzen DE; Anderson LI
Eur J Pharmacol; 1998 Jan; 341(1):23-32. PubMed ID: 9489852
[TBL] [Abstract][Full Text] [Related]
13. Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants.
Gross JD; Kaski SW; Schroer AB; Wix KA; Siderovski DP; Setola V
J Psychopharmacol; 2018 Feb; 32(2):191-203. PubMed ID: 29364035
[TBL] [Abstract][Full Text] [Related]
14. Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release.
Quarta D; Naylor CG; Barik J; Fernandes C; Wonnacott S; Stolerman IP
Psychopharmacology (Berl); 2009 Apr; 203(2):399-410. PubMed ID: 18758759
[TBL] [Abstract][Full Text] [Related]
15. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
16. Effect of nicotine pretreatment on striatal dopaminergic system in rats.
Fung YK; Lau YS
Pharmacol Biochem Behav; 1989 Jan; 32(1):221-6. PubMed ID: 2734333
[TBL] [Abstract][Full Text] [Related]
17. Nicotine treatment produces persistent increases in amphetamine-stimulated locomotor activity in periadolescent male but not female or adult male rats.
Collins SL; Montano R; Izenwasser S
Brain Res Dev Brain Res; 2004 Nov; 153(2):175-87. PubMed ID: 15527885
[TBL] [Abstract][Full Text] [Related]
18. Interaction of stress and stimulants in female rats: Role of chronic stress on later reactivity to methamphetamine.
Anderson EM; McFadden LM; Matuszewich L
Behav Brain Res; 2019 Dec; 376():112176. PubMed ID: 31449910
[TBL] [Abstract][Full Text] [Related]
19. The influence of nicotine pretreatment on mesoaccumbens dopamine overflow and locomotor responses to D-amphetamine.
Birrell CE; Balfour DJ
Psychopharmacology (Berl); 1998 Nov; 140(2):142-9. PubMed ID: 9860104
[TBL] [Abstract][Full Text] [Related]
20. Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats.
Whiteaker P; Garcha HS; Wonnacott S; Stolerman IP
Br J Pharmacol; 1995 Oct; 116(3):2097-105. PubMed ID: 8640351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
